A Phase I study of IDH305 in patients with advanced malignancies that harbor IDH1R132 mutations

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507421-41-00

Acronym

CIDH305X2101

Enrollment

Registered

2024-03-14

Start date

2015-07-20

Completion date

Unknown

Last updated

2025-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced malignancies that harbor IDH1R132 mutations

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026